Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome. Moeder CB, Giltnane JM, Harigopal M, Molinaro A, Robinson A, Gelmon K, Huntsman D, Camp RL, Rimm DL, American Society of Clinical Oncology, College of American Pathologists (2007) J Clin Oncol 25: 5418-25 Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers. Guix M, Granja Nde M, Meszoely I, Adkins TB, Wieman BM, Frierson KE, Sanchez V, Sanders ME, Grau AM, Mayer IA, Pestano G, Shyr Y, Muthuswamy S, Calvo B, Krontiras H, Krop IE, Kelley MC, Arteaga CL (2008) J Clin Oncol 26: 897-906 Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ (2007) Cell Metab 5: 143-9 TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer. Bhola NE, Balko JM, Dugger TC, Kuba MG, Sánchez V, Sanders M, Stanford J, Cook RS, Arteaga CL (2013) J Clin Invest 123: 1348-58 Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Sinars CR, Cheung-Flynn J, Rimerman RA, Scammell JG, Smith DF, Clardy J (2003) Proc Natl Acad Sci U S A 100: 868-73 Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Tranguch S, Cheung-Flynn J, Daikoku T, Prapapanich V, Cox MB, Xie H, Wang H, Das SK, Smith DF, Dey SK (2005) Proc Natl Acad Sci U S A 102: 14326-31 Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Bailey LR, Roodi N, Dupont WD, Parl FF (1998) Cancer Res 58: 5038-41 Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene. Cai Q, Gao YT, Wen W, Shu XO, Jin F, Smith JR, Zheng W (2003) Cancer Res 63: 5727-30 Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk. Cui Y, Deming-Halverson SL, Beeghly-Fadiel A, Lipworth L, Shrubsole MJ, Fair AM, Shu XO, Zheng W (2014) Clin Cancer Res 20: 1169-78 Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, Osteen KG (2006) J Clin Endocrinol Metab 91: 1554-60 The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status. Baglia ML, Zheng W, Li H, Yang G, Gao J, Gao YT, Shu XO (2016) Int J Cancer 139: 742-8 Associations of reproductive time events and intervals with breast cancer risk: a report from the Shanghai Breast Cancer Study. Huang Z, Beeghly-Fadiel A, Gao YT, Zheng Y, Dai Q, Lu W, Zheng W, Shu XO (2014) Int J Cancer 135: 186-95 African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P (2004) Cancer 101: 1293-301 p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF (1994) Cancer 73: 2147-56 Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort. Giltnane JM, Moeder CB, Camp RL, Rimm DL (2009) Cancer 115: 2400-9 Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. De Los Santos JF, Cantor A, Amos KD, Forero A, Golshan M, Horton JK, Hudis CA, Hylton NM, McGuire K, Meric-Bernstam F, Meszoely IM, Nanda R, Hwang ES (2013) Cancer 119: 1776-83 Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population. Xu WH, Long JR, Zheng W, Ruan ZX, Cai Q, Cheng JR, Xiang YB, Shu XO (2009) Cancer 115: 2693-700 The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Rokicki J, Das PM, Giltnane JM, Wansbury O, Rimm DL, Howard BA, Jones FE (2010) Mol Cancer 9: 150 Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W (2001) Br J Cancer 85: 372-8 Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Bao PP, Shu XO, Gao YT, Zheng Y, Cai H, Deming SL, Ruan ZX, Su Y, Gu K, Lu W, Zheng W (2011) Am J Epidemiol 174: 661-71 Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study. Adams SA, Matthews CE, Hebert JR, Moore CG, Cunningham JE, Shu XO, Fulton J, Gao Y, Zheng W (2006) Cancer Epidemiol Biomarkers Prev 15: 1170-8 Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Adegoke OJ, Shu XO, Gao YT, Cai Q, Breyer J, Smith J, Zheng W (2004) Breast Cancer Res Treat 85: 239-45 The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk. Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Newcomb PA (2013) Breast Cancer Res Treat 140: 427-34 Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Igarashi TM, Bruner-Tran KL, Yeaman GR, Lessey BA, Edwards DP, Eisenberg E, Osteen KG (2005) Fertil Steril 84: 67-74 Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective study. Xie M, Zhu X, Liu Z, Shrubsole M, Varma V, Mayer IA, Dai Q, Chen Q, You S (2012) PLoS One 7: e35198 Preconception omega-3 fatty acid supplementation of adult male mice with a history of developmental 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure prevents preterm birth in unexposed female partners. McConaha ME, Ding T, Lucas JA, Arosh JA, Osteen KG, Bruner-Tran KL (2011) Reproduction 142: 235-41 Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, Cai Q, Lu W, Shu XO (2011) BMC Cancer 11: 292 Developmental dioxin exposure of either parent is associated with an increased risk of preterm birth in adult mice. Ding T, McConaha M, Boyd KL, Osteen KG, Bruner-Tran KL (2011) Reprod Toxicol 31: 351-8 Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Nayyar T, Bruner-Tran KL, Piestrzeniewicz-Ulanska D, Osteen KG (2007) Reprod Toxicol 23: 326-36 Replication study for reported SNP associations with breast cancer survival. Beeghly-Fadiel A, Zheng W, Lu W, Long J, Zheng Y, Cai H, Gu K, Chen Z, Cai Q, Gao YT, Shu XO (2012) J Cancer Res Clin Oncol 138: 1019-26 The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen. Kurita T, Medina R, Schabel AB, Young P, Gama P, Parekh TV, Brody J, Cunha GR, Osteen KG, Bruner-Tran KL, Gold LI (2005) Differentiation 73: 313-22 Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Fair AM, Sanderson M, Shu XO, Kelley MC, Zheng W (2014) Clin Breast Cancer 14: 417-25 Prognostic factors in patients with metastatic breast cancer at the time of diagnosis. Ren Z, Li Y, Hameed O, Siegal GP, Wei S (2014) Pathol Res Pract 210: 301-6 Coordinate patterns of estrogen receptor, progesterone receptor, and Wilms tumor 1 expression in the histopathologic distinction of ovarian from endometrial serous adenocarcinomas. Fadare O, James S, Desouki MM, Khabele D (2013) Ann Diagn Pathol 17: 430-3 Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs. Wei S, Li Y, Siegal GP, Hameed O (2011) Ann Diagn Pathol 15: 79-83
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.